Provided by Tiger Trade Technology Pte. Ltd.

Johnson & Johnson

270.24
+2.871.07%
Pre-market: 271.631.39+0.51%06:48 EDT
Volume:6.19M
Turnover:1.67B
Market Cap:651.09B
PE:31.29
High:272.66
Open:267.83
Low:267.00
Close:267.37
52wk High:276.47
52wk Low:173.33
Shares:2.41B
Float Shares:2.40B
Volume Ratio:0.95
T/O Rate:0.26%
Dividend:5.24
Dividend Rate:1.94%
EPS(TTM):8.64
EPS(LYR):11.03
ROE:25.74%
ROA:8.59%
PB:7.66
PE(LYR):24.49

Loading ...

Daiwa Securities Adjusts PT on Johnson & Johnson to $260 From $246, Maintains Outperform Rating

MT Newswires Live
·
Jul 22

J&J EVP Vanessa Broadhurst Disposes of 23,054 Common Shares Worth $5.79 Million

Reuters
·
Jul 22

3 ‘Strong Buy’ Dividend Aristocrat Stocks for Steady Cash Flow, 7/21/26

TIPRANKS
·
Jul 22

Johnson & Johnson Names Chemt Biotechnology, Hill Research, Prima Mente, Waypoint Bio as Quickfire Challenge Awardees, Allocates USD 400,000 Grants

Reuters
·
Jul 21

Perrigo Co. PLC Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Jul 21

J & J SNACK FOODS SCHEDULES FISCAL 2026 THIRD QUARTER EARNINGS CONFERENCE CALL AND WEBCAST

GlobeNewswire
·
Jul 21

Analysts Have Conflicting Sentiments on These Healthcare Companies: 10x Genomics (TXG), Elevance Health (ELV) and Johnson & Johnson (JNJ)

TIPRANKS
·
Jul 17

Why This Surgical Robot Stock is Still a Buy During Its Worst Day in 4 Years

Dow Jones
·
Jul 17

Jefferies Sticks to Their Hold Rating for J & J Snack Foods (JJSF)

TIPRANKS
·
Jul 17

Perrigo Co. PLC Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 17

Johnson & Johnson upgraded to Buy at Freedom Broker after strong quarter

TIPRANKS
·
Jul 17

Why Abbott Stock is Having Its Best Day in 24 Years

Dow Jones
·
Jul 16

Johnson & Johnson Launches Deep Tissue Healing Quickfire Challenge, Sets Virtual Pitch Session for Finalists

Reuters
·
Jul 16

Johnson & Johnson's Innovative Medicine Segment Momentum Continues to Build into 2027, RBC Says

MT Newswires Live
·
Jul 16

Johnson & Johnson Price Target Maintained with a $287.00/share by RBC Capital

Dow Jones
·
Jul 16

Johnson & Johnson Announces Quarterly Dividend of US$ 0.09 Per BDR for Jnjb34 Program

Reuters
·
Jul 16

Johnson & Johnson is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Jul 16

Johnson & Johnson's Tremfya and Icotyde Drive Strong Performance, Lifting Full-Year Outlook

Deep News
·
Jul 16

22nd Century Group Appoints Katherine Rouse-bailey as VP of Marketing

Reuters
·
Jul 16

Scotiabank Reaffirms Their Buy Rating on Johnson & Johnson (JNJ)

TIPRANKS
·
Jul 16